Precise Spatial Multiplexing with ChipCytometry
Please log in for more information
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Subscribe to The Pathologist Newsletters
Canopy Biosciences was formed in 2016 and rapidly built a comprehensive portfolio of products and services for spatial biology, multi-omics, and bioprocessing. Canopy’s technologies include precise spatial multiplexing in cells and tissue samples via the ZellScannerONE instrument platform, ultrasensitive DNA sequencing (RareSeq), RNA-Seq, and gene expression analysis. Canopy Biosciences is headquartered in St. Louis, Missouri, with additional CRO sites in California and Germany to serve researchers at universities, research institutions, and biotechnology and pharmaceutical companies worldwide. Canopy was acquired by Bruker Corporation (Nasdaq: BRKR) in 2020. Additional information is available at www.canopybiosciences.com.